Germany's first BRIDGE by Evotec, Bristol Myers Squibb and five leading research institutions has made an initial selection from among numerous projects. Here, beLAB2122 shows that the combination of forces can raise the potential of academic research quickly and efficiently.
Read more in this article published in transcript 3.2022 (Biocom)
tk322Cover_Adzusammengefügt
.pdf
Download PDF • 24.35MB